Capital Flow Monitor · Sponsors · CIK 2008372
Rapalogix Health, Inc.
3129 TIGER RUN COURT, CARLSBAD, CA, 92010 · (760) 707-2412
Biotechnology · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$25.0M
Sold
$19.1M
% sold
76.5%
Investors
28
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | D ·current | 506(b) | $25.0M | $19.1M | 76.5% | 28 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Rahul Mehta — Executive Officer, Carlsbad, CA
-
James Peyer — Director, Carlsbad, CA
1 other raise
- Cambrian BioPharma Inc $123.8M of $129.8M · 95.4%
-
Juliette Han — Director, Carlsbad, CA
1 other raise
- Cambrian BioPharma Inc $123.8M of $129.8M · 95.4%
- Neetu Dhaliwal — Director, Carlsbad, CA
- Brent Saunders — Director, Carlsbad, CA
- Doris Day — Director, Carlsbad, CA
-
David Nicholson — Director, Carlsbad, CA
1 other raise
- Volastra Therapeutics, Inc. $30.1M of $30.1M · 100.0%
- Craig Gordon — Director, Carlsbad, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.